UniProt E9PYI1
Zinc finger protein 568 (E9PYI1)
Zinc finger protein 568 (UniProt E9PYI1): 6 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound, 28 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- E9PYI1
- Protein
- Zinc finger protein 568
- Experimental structures
- 6
- Predicted models
- 1
- Ligands
- 2
- Pockets
- 28 · 3 records with a druggable one
Structures
7 records of E9PYI1 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 5V3J | mouseZFP568-ZnF1-10 in complex with DNA | x-ray diffraction | E, F | ZN, MG | 12 (best 0.78) |
| 5V3J | MOUSEZFP568-ZNF1-10 in complex with DNA | x-ray diffraction | E, F | ZN, MG | — |
| 5V3M | mouseZFP568-ZnF1-11 in complex with DNA | x-ray diffraction | C | ZN | 6 (best 0.74) |
| 5V3M | MOUSEZFP568-ZNF1-11 in complex with DNA | x-ray diffraction | C | ZN | — |
| 5WJQ | mouseZFP568-ZnF2-11 in complex with DNA | x-ray diffraction | D | ZN | 8 (best 0.71) |
| 5WJQ | MOUSEZFP568-ZNF2-11 in complex with DNA | x-ray diffraction | D | ZN | — |
| E9PYI1 | AlphaFold monomer V2.0 prediction for zinc finger protein 568 (E9PYI1) | predicted | A | — | 2 (best 0.36) |
Ligands
Experiment against prediction
- 5WJQ chain D against the predicted model E9PYI1: TM-score 0.68, RMSD 3.89 Å
- 5WJQ chain D against the predicted model E9PYI1: TM-score 0.68, RMSD 3.89 Å
- 5V3M chain C against the predicted model E9PYI1: TM-score 0.61, RMSD 3.60 Å
- 5V3M chain C against the predicted model E9PYI1: TM-score 0.61, RMSD 3.60 Å
- 5V3J chain F against the predicted model E9PYI1: TM-score 0.60, RMSD 3.75 Å
- 5V3J chain F against the predicted model E9PYI1: TM-score 0.60, RMSD 3.75 Å
- 5V3J chain E against the predicted model E9PYI1: TM-score 0.58, RMSD 3.87 Å
- 5V3J chain E against the predicted model E9PYI1: TM-score 0.58, RMSD 3.87 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.